Skip to main content

Nanogen Gets $2.5M from NIH to Develop Prototype Diagnostic for Sepsis, Pneumonia

NEW YORK, Aug. 1 (GenomeWeb News) - Nanogen has received a $2.5 million grant from the National Institute of Allergy and Infectious Diseases to develop a prototype diagnostic for sepsis and community-acquired pneumonia, the company said today.

 

Under the five-year grant, Nanogen will collaborate with the Medical College of Wisconsin to provide an automated diagnostic system to rapidly detect bacteria and viruses that cause sepsis and pneumonia.

 

Mortality from sepsis ranges from 28 percent to 50 percent, according to the company, and pneumonia is the seventh leading cause of death in the US.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.